Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act

This cohort study assesses rates at which orphan drugs approved by the US Food and Drug Administration were also approved for supplemental (follow-on) indications.

Detalles Bibliográficos
Autores principales: Chambers, James D., Clifford, Katherine A., Enright, Daniel E., Neumann, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427936/
https://www.ncbi.nlm.nih.gov/pubmed/37581890
http://dx.doi.org/10.1001/jamanetworkopen.2023.29006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427936/
https://www.ncbi.nlm.nih.gov/pubmed/37581890
http://dx.doi.org/10.1001/jamanetworkopen.2023.29006

Ejemplares similares